Anorexia and Cachexia

作者: Takao Ohnuma* , James F. Holland

DOI: 10.1007/978-1-59745-291-5_4

关键词:

摘要: Cachexia is a complex syndrome presenting wasting of muscle and adipose tissues, weight loss, anorexia, early satiety, fatigue, anemia, hyperlipidemia, systemic inflammatory responses, often hypercatabolic state. differs from starvation, where visceral proteins are also depleted. Profound anorexia satiety partly responsible, but metabolic abnormalities the major cause cachexia. Mechanisms cachexia include production cytokines including TNF-α, Interleuken-1 (IL-1), IL-6, IFN-γ; secretion tumor byproducts, which lipolytic factors proteolysis-inducing factor; hormonal aberration; prostaglandin elevation; possible dysfunction neuropeptidergic circuits; derangement produced by treatment. A variety agents have been used in attempts to reverse cachexia, corticosteroids, megestrol acetate medroxyprogesterone acetate, anabolic steroids, cannabinoids, growth hormones, somatostatin GHRP-2, insulin-like factor 1, metoclopramide cisapride, hydrazine sulfate, anti-inflammatory such as indomethacin ibuprofen, pentoxifylline lisofylline, proteasome inhibitors NF-κB inhibitors, clenbuterol, thalidomide, adenosine triphosphate, 5′-deoxy-5-fluorouridine, proinflammatory-cytokine proinflammatory cytokine antibodies cytokines, eicosapentaenoic acid, enteral parenteral nutrition, branched-chain amino acids, orexigenic mediators, melatonin cyproheptadine. Currently, most commonly agent acetate; however, megestrol-induced gain mainly water fat, rather than protein. Side effects thromboembolic phenomena. In studies, thalidomide appear effective at attenuating loss lean body mass cancer Development that prevent or eagerly awaited.

参考文章(289)
Filippo Rossi-Fanelli, Alessandro Laviano, Role of brain tryptophan and serotonin in secondary anorexia. Advances in Experimental Medicine and Biology. ,vol. 527, pp. 225- 232 ,(2003) , 10.1007/978-1-4615-0135-0_26
D. S. Martin, D. Spriggs, J. A. Koutcher, A concomitant ATP-depleting strategy markedly enhances anticancer agent activity. Apoptosis. ,vol. 6, pp. 125- 131 ,(2001) , 10.1023/A:1009692631748
, Kristine A. Nelson, T. Declan Walsh, Metoclopramide in anorexia caused by cancer-associated dyspepsia syndrome (CADS). Journal of Palliative Care. ,vol. 9, pp. 14- 18 ,(1993) , 10.1177/082585979300900203
Kristine A. Nelson, T. Declan Walsh, Finbarr G. Sheehan, Peter B. O'Donovan, Gary W. Falk, Assessment of upper gastrointestinal motility in the cancer-associated dyspepsia syndrome. Journal of Palliative Care. ,vol. 9, pp. 27- 31 ,(1993) , 10.1177/082585979300900105
A J McGeer, K O'Rourke, A S Detsky, Parenteral nutrition in cancer patients undergoing chemotherapy: a meta-analysis. Nutrition. ,vol. 6, pp. 233- 240 ,(1990)
L Tessitore, P Costelli, F M Baccino, Pharmacological interference with tissue hypercatabolism in tumour-bearing rats. Biochemical Journal. ,vol. 299, pp. 71- 78 ,(1994) , 10.1042/BJ2990071
Fikret Arpaci, Mahmut Ilker Yilmaz, Ahmet Ozet, Hasan Ayta, Bekir Ozturk, Seref Komurcu, Metin Ozata, Low serum leptin level in colon cancer patients without significant weight loss. Tumori. ,vol. 88, pp. 147- 149 ,(2002) , 10.1177/030089160208800213
Lydie Combaret, Cécile Rallière, Daniel Taillandier, Keiji Tanaka, Didier Attaix, Manipulation of the ubiquitin-proteasome pathway in cachexia: pentoxifylline suppresses the activation of 20S and 26S proteasomes in muscles from tumor-bearing rats Molecular Biology Reports. ,vol. 26, pp. 95- 101 ,(1999) , 10.1023/A:1006955832323
CA Baile, WM Zinn, J Mayer, Effects of lactate and other metabolites on food intake of monkeys. American Journal of Physiology. ,vol. 219, pp. 1606- 1613 ,(1970) , 10.1152/AJPLEGACY.1970.219.6.1606
E. Roca, S. Carraro, R. Chacon, L. Cedaro, E. Bruera, Action of oral methylprednisolone in terminal cancer patients: a prospective randomized double-blind study. Cancer treatment reports. ,vol. 69, pp. 751- 754 ,(1985)